Clinical Trials Browser

Adenoviridae Infections

NCT02705196 2026-02-24

LOAd703 Oncolytic Virus Therapy for Pancreatic Cancer

Phase 1/2 Completed

51 enrolled

Gastrointestinal

Adenoviridae Infections, Neoplasms, Pancreatic Neoplasms

NCT02048332 2025-12-16

VSTs

Phase 1/2 Recruiting

750 enrolled

Adenoviridae Infections, Virus Diseases, Epstein-Barr Virus Infections

NCT06763965 2025-12-02

A Clinical Study Evaluating the Safety and Efficacy of BioTTT001 in Patients With Recurrent/Progressive High-grade Glioma.

Phase 1/2 Enrolling by invitation

30 enrolled

CNS

Adenoviridae Infections, Glioma

NCT06215846 2025-11-26

A Clinical Study Evaluating the Safety and Efficacy of BioTTT001 in Patients With Malignant Solid Tumors

Phase 1 Enrolling by invitation

12 enrolled

Adenoviridae Infections

NCT05271318 2025-11-03

PROTA

Phase 1/2 Recruiting

29 enrolled

Adenoviridae Infections

NCT05101213 2025-10-14

Study Assessing the Feasibility, Safety and Efficacy of Genetically Engineered Glucocorticoid Receptor Knock Out Virus Specific CTL Lines for Viral Infections in Immunosuppressed Cancer Patients

Phase 1 Recruiting

30 enrolled

Other hematologic neoplasm

Adenoviridae Infections, Cytomegalovirus Infections, Hematologic Neoplasms

NCT06909110 2025-08-14

Viral Specific T-Lymphocytes to Treat Infection With Adenovirus, Cytomegalovirus or Epstein-Barr Virus in Patients With Compromised Immunity

Phase 1/2 Recruiting

25 enrolled

Adenoviridae Infections, Cytomegalovirus Infections, Epstein-Barr Virus Infections

NCT04013802 2025-08-08

TETRAVI

Phase 1 Recruiting

47 enrolled

Adenoviridae Infections, Virus Diseases, Epstein-Barr Virus Infections

NCT06926894 2025-07-31

R-MVST Cells for Treatment of Viral Infections in Children and Young Adults

Phase 1 Recruiting

18 enrolled

Adenoviridae Infections, Cytomegalovirus Infections, Immunologic Deficiency Syndromes, Epstein-Barr Virus Infections

NCT04832607 2025-07-18

TRACE

Phase 3 Recruiting

149 enrolled

Adenoviridae Infections, Cytomegalovirus Infections, Epstein-Barr Virus Infections

NCT06027879 2025-06-25

Gamma Capture

Phase 1/2 Enrolling by invitation

25 enrolled

Adenoviridae Infections, Cytomegalovirus Infections, Epstein-Barr Virus Infections

NCT03475212 2025-05-11

ACES

Phase 1/2 Active not recruiting

52 enrolled

Primary Immunodeficiency Diseases, Adenoviridae Infections, Cytomegalovirus Infections, Epstein-Barr Virus Infections

NCT03754933 2025-03-27

Safety and Efficacy of Repeat Administration of Ad/PNP and Fludarabine Phosphate in Patients With Local Head/Neck Cancer

Phase 1/2 Completed

10 enrolled 22 charts

Head & Neck

Squamous Cell Carcinoma of Head and Neck, Adenoviridae Infections, Head and Neck Neoplasms

Clinical Trials

TUNIMO

LOAd703 Oncolytic Virus Therapy for Pancreatic Cancer

VSTs

A Clinical Study Evaluating the Safety and Efficacy of BioTTT001 in Patients With Recurrent/Progressive High-grade Glioma.

A Clinical Study Evaluating the Safety and Efficacy of BioTTT001 in Patients With Malignant Solid Tumors

PROTA

Study Assessing the Feasibility, Safety and Efficacy of Genetically Engineered Glucocorticoid Receptor Knock Out Virus Specific CTL Lines for Viral Infections in Immunosuppressed Cancer Patients

Viral Specific T-Lymphocytes to Treat Infection With Adenovirus, Cytomegalovirus or Epstein-Barr Virus in Patients With Compromised Immunity

TETRAVI

R-MVST Cells for Treatment of Viral Infections in Children and Young Adults

TRACE

Gamma Capture

ACES

Safety and Efficacy of Repeat Administration of Ad/PNP and Fludarabine Phosphate in Patients With Local Head/Neck Cancer